AOD 9604: What the Research Actually Shows About This HGH Fragment
A breakdown of AOD 9604 (HGH Fragment 176-191), its fat-loss mechanism, clinical trial results, safety data, and how it compares to melanotan peptides and myostatin inhibitors.
Peptides Specialty
88 source-based articles maintained by the HealthRX.com Editorial Team.
88articles
6topic areas covered
Jul 14, 2025latest review
Peptides Specialty library
Showing 88 of 88 clinical reviews.
AOD-9604 Online: Cost, Candidacy, Prescription Rules, and What the Evidence Actually Shows
A guide to AOD-9604 (HGH fragment 176-191): how telehealth access works, what compounded pricing looks like, who might be a candidate, and an honest look at the animal and human data behind it.
AOD9604 vs Frag 176-191: Which Fat-Loss Peptide Is Right for You?
A clinical comparison of AOD9604 and HGH Fragment 176-191, plus brief comparisons of BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin, with evidence quality and regulatory status flagged for each.
ARA 290: What It Is, How It Works, and What the Research Actually Shows
A deep-dive into ARA 290 (cibinetide), a non-hematopoietic erythropoietin peptide fragment studied for neuropathic pain, inflammation, and metabolic repair. Includes trial data, dosing context, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
Are Peptides Legal in the US? A Complete Clinical Guide
A guide covering US peptide legality, FDA status, compounding rules, drug testing, injection technique, oral bioavailability, and cycling protocols with primary-source citations.
Argireline: How It Works, What the Evidence Says, and How It Compares to Other Cosmetic Peptides
A guide to argireline (acetyl hexapeptide-3), SNAP-8, Matrixyl, copper peptides, and topical dermorphin. Includes dosing, mechanism, clinical trial data, and how to choose the right peptide for your skin goals.
BPC-157 for Gut Health: What the Evidence Actually Shows
A guide to BPC-157 for gut healing, covering mechanisms, dosing, comparisons with thymosin alpha-1, thymulin, larazotide, and KPV, plus real trial data and clinical context.
BPC-157 Fragments: What They Are, How They Work, and How They Compare to TB-500 and Regenerative Peptide Stacks
A breakdown of BPC-157 fragments, their proposed mechanism of action, comparison with TB-500/Ac-SDKP, GHRP-2 vs GHRP-6, and how regenerative peptide stacks are assembled, along with what the evidence does and does not support.
BPC-157 vs TB-500: Which Peptide Should You Use for Recovery?
A clinical comparison of BPC-157 and TB-500 covering mechanisms, the state of the human and animal evidence, dosing patterns reported in research literature, stacking, and regulatory status.
Can Peptides Be Taken Orally? Routes, Absorption, and What Actually Works
Most peptides are destroyed in the gut before reaching the bloodstream. Learn which peptides can be taken orally, which require injection, and what the science says about absorption, legality, and safety.
Can Peptides Show on a Drug Test?
A guide on whether therapeutic peptides appear on standard urine, blood, or sports drug tests, plus their legal status, injection considerations, oral bioavailability, and cycling protocols.
Cerebrolysin, Semax, Selank, Dihexa, and Pinealon: A Clinical Guide to Neurotropic Peptides
A guide to the five most-studied neurotropic peptides: cerebrolysin, semax, selank, dihexa, and pinealon. Covers mechanisms, clinical evidence, dosing, safety, and how to tell which patients may benefit.
Copper Peptides Beyond GHK: Argireline, Matrixyl, SNAP-8, and the Full Cosmetic Peptide Map
A guide to cosmetic peptides beyond GHK-Cu, covering argireline, matrixyl, SNAP-8, and topical dermorphin analogues. Includes real trial data, dosing, and how each peptide works mechanistically.
Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, GHRP-2 vs Ipamorelin
A head-to-head clinical comparison of eight cosmetic and specialty peptides, including BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin, with dosing, mechanisms, safety profiles, and guidance on which to choose.
Davunetide (NAP Peptide): Clinical Evidence, Mechanisms, and Comparisons With Semax, Selank, Cerebrolysin, and Dihexa
A deep-dive into davunetide (NAP/AL-108/AL-208), covering its mechanism of action, clinical trial data from PSP and AD studies, dosing, safety, and how it compares with semax, selank, cerebrolysin, and dihexa for neuroprotection.
Dermorphin Topical: What the Science Says About Skin Peptides for Anti-Aging
A clinical deep-dive into dermorphin topical applications, argireline, Matrixyl, SNAP-8, and copper peptides beyond GHK-Cu. Evidence-based guidance on doses, mechanisms, and what to realistically expect.
Dihexa: What It Is, How It Works, and What the Evidence Actually Shows
A clinical deep-dive into dihexa, covering mechanism of action, research data, comparisons with semax, selank, cerebrolysin, and pinealon, dosing ranges used in trials, and safety considerations reviewed by HealthRX.com physicians.
DSIP, PT-141, Kisspeptin-10, and Oxytocin: A Clinical Guide to Specialty Peptides
A breakdown of four specialty peptides, DSIP, PT-141 (bremelanotide), kisspeptin-10, and oxytocin, covering mechanisms, dosing, evidence, and clinical use cases.
Epitalon Online: Cost, Prescription Requirements, and What the Research Actually Shows
A guide to getting Epitalon online: candidacy, typical cost, the telehealth prescription process, and an honest look at the evidence behind this investigational peptide.
Epitalon vs TB-500 for Longevity: Which Peptide Fits Your Protocol?
A comparison of Epitalon and TB-500 for longevity, covering mechanisms, dosing, evidence, and how they stack against BPC-157, IGF-1 LR3, Semax, Selank, GHRP-2, and Ipamorelin.
Epitalon, MOTS-c, SS-31, Humanin, and FOXO4-DRI: What the Research Actually Shows
A guide to five longevity peptides, covering mechanisms, clinical and preclinical evidence, dosing data, regulatory status, and how to evaluate them safely.
FDA 503A Compounded Peptides: Safety, Legality, Purity, and Storage
A guide to FDA 503A compounded peptides covering legal status, purity standards, sterility testing, storage stability, and how they differ from unregulated research peptides.
FDA Sterility Testing for Compounded Peptides Explained
FDA sterility testing requires USP <71> sterility, endotoxin, and potency tests under 503A/503B before release, rules research chemical peptides skip entirely.
FOXO4-DRI: What the Research Actually Shows About This Senolytic Peptide
A guide to FOXO4-DRI, covering its mechanism, the 2017 mouse data, human evidence gaps, safety unknowns, and how it compares with epitalon, MOTS-c, SS-31, and humanin.
GHRP-2 vs GHRP-6: Which Works Better for GH and Appetite
GHRP-2 raises GH about 25-50% more than GHRP-6 but causes less hunger; GHRP-6 stimulates strong appetite fast. Compare potency, cortisol effects, and uses.
GHRP-2 vs Ipamorelin: Which Growth Hormone Secretagogue Is Right for You?
A clinical comparison of GHRP-2 and ipamorelin covering mechanism, dosing, side-effect profiles, and how each fits into a broader peptide stack including BPC-157, TB-500, IGF-1 LR3, Semax, Selank, and Epitalon.
Hexarelin: Uses, Dosing, Safety, and How It Compares to Related Peptides
A guide to hexarelin, covering its mechanism, clinical evidence, dosing protocols, safety data, and comparisons with epitalon, MOTS-c, SS-31, and humanin.
HGH Frag 176-191: What the Evidence Actually Shows About This Lipolytic Peptide
A clinically grounded review of HGH Fragment 176-191 (AOD 9604), covering mechanism, fat-loss data, dosing, side effects, melanotan comparisons, and myostatin inhibitor context, prepared by the HealthRX.com Editorial Team.
Humanin: What the Research Actually Shows About This Mitochondrial Peptide
A guide to humanin, covering its mechanism, reported benefits, dosing data from published trials, comparisons with epitalon, MOTS-c, SS-31, and FOXO4-DRI, and what the current FDA regulatory landscape means for patients.
IGF-1 DES: Mechanism, Dosing, and Clinical Evidence
A guide to IGF-1 DES: how it differs from IGF-1 LR3, what the receptor-binding data show, realistic dosing windows, and when a prescriber might consider it.
IGF-1 LR3: Mechanisms, Dosing, Safety, and Clinical Evidence
A comprehensive clinical guide to IGF-1 LR3, covering its molecular mechanism, differences from native IGF-1 and IGF-1 DES, IGFBP modulation, MGF comparison, dosing protocols, and the current evidence base with primary-source citations.
IGF-1 Peptide Guide: LR3, DES, and Mecasermin Explained
IGF-1 LR3 and DES are unapproved research chemicals with no human trials. Learn how they differ from mecasermin, the only FDA-approved IGF-1 drug.
IGF-1 vs IGF-1 LR3: Which Peptide Actually Builds Muscle and Burns Fat?
A clinical comparison of IGF-1 and IGF-1 LR3: half-life, receptor binding, anabolic potency, dosing protocols, side-effect profiles, and how each fits into a broader peptide stack with BPC-157, TB-500, GHRP-2, Ipamorelin, Semax, Selank, and Epitalon.
IGF-BP Modulation: How Insulin-Like Growth Factor Binding Proteins Control Muscle, Fat, and Recovery
A guide to IGF-1, IGF-1 LR3, IGF-1 DES, MGF, and the binding-protein system that gates their activity. Includes mechanism context, dosing considerations, and safety boundaries pending qualified medical review.
Immune Peptide Stack: Thymosin Alpha-1, Thymulin, KPV, and Larazotide Explained
A guide to building an immune peptide stack. Covers thymosin alpha-1, thymulin, KPV, and larazotide with doses, trial data, safety, and how each peptide fits a specific immune target.
Kisspeptin 10: What It Does, How It Works, and How It Compares to PT-141, Oxytocin, and DSIP
A guide to kisspeptin 10, covering its mechanism, dosing, evidence base, and comparison with PT-141 (bremelanotide), therapeutic oxytocin, and DSIP. Includes real trial data and prescriber guidance.
KPV Systemic: Immune Peptides, How They Work, and What the Evidence Shows
A guide to KPV and systemic immune peptides, including thymosin alpha-1, thymulin, and larazotide. Covers mechanisms, dosing evidence, regulatory status, and stacking considerations.
Larazotide: Immune Peptides, Gut Permeability, and the Clinical Evidence Behind Thymosin Alpha-1, KPV, and Thymulin
A deep dive into larazotide, thymosin alpha-1, KPV, and thymulin: how each peptide works, what the human trial data actually show, dosing ranges used in practice, and how clinicians are beginning to stack them.
Leptin Fragments, AOD 9604, HGH Frag 176-191, and Melanotans: What the Evidence Actually Shows
A guide to leptin-derived peptides including AOD 9604, HGH fragment 176-191, melanotan 1, and melanotan 2. Covers mechanisms, clinical trial data, dosing research, and real safety risks.
LF 15 Camel: Thymosin Alpha-1, Thymulin, Larazotide, and KPV Systemic Peptides Explained
A guide to the LF-15 Camel peptide stack, covering thymosin alpha-1, thymulin, larazotide, and KPV systemic. Includes mechanisms, dosing protocols, clinical trial data, and regulatory status.
Longevity Peptide Stacks: Epitalon, MOTS-C, SS-31, and Humanin Explained
A guide to longevity peptide stacks, covering Epitalon, MOTS-C, SS-31, and Humanin: mechanisms, clinical evidence, dosing protocols, and safety considerations.
Matrixyl, Argireline, Copper Peptides, and SNAP-8: What the Evidence Actually Shows
A guide to topical peptides for skin aging, covering Matrixyl (palmitoyl pentapeptide-4), Argireline (acetyl hexapeptide-3), SNAP-8, GHK-Cu, and emerging compounds. Includes trial data, doses, and practical protocol guidance.
Melanotan 1: What It Is, How It Works, and What the Evidence Actually Shows
A clinical breakdown of Melanotan 1 (afamelanotide), its FDA-designated status, melanocortin receptor mechanism, real trial data, and how it compares to AOD 9604, HGH Frag 176-191, Melanotan 2, and experimental myostatin inhibitors.
Melanotan 2 Risk: What the Evidence Actually Shows
A clinical review of melanotan 2 risks, covering cardiovascular effects, melanoma risk, nausea, and comparisons with AOD 9604, HGH Frag 176-191, melanotan 1, and myostatin inhibitors. prepared by the HealthRX.com Editorial Team.
Melatonin Peptide Skin: What the Evidence Says About Melatonin, Argireline, Matrixyl, SNAP-8, and Copper Peptides
A guide to melatonin and cosmetic peptides for skin aging, covering argireline, matrixyl, SNAP-8, GHK-Cu, and emerging copper peptide variants with real trial data and dosing context.
MGF (Mechano Growth Factor): What It Is, How It Works, and What the Research Shows
A guide to MGF mechano growth factor, its relationship to IGF-1 splice variants, IGF-1 LR3, IGF-1 Des, and IGFBP modulation, with full citations to primary research.
MOTS-c Online: Cost, Candidacy, and How the Telehealth Process Works
A clear, evidence-graded guide to getting MOTS-c through telehealth: what the peptide is, what the 2015 Cell Metabolism study actually showed, realistic cost, and how a prescriber decides if it fits you.
MOTS-c, Epitalon, SS-31, Humanin, and FOXO4-DRI: What the Research Actually Shows
A guide to mitochondrial and longevity peptides including MOTS-c, Epitalon, SS-31, Humanin, and FOXO4-DRI. Covers mechanisms, clinical and preclinical evidence, dosing, safety, and regulatory status.
Myostatin Inhibitors and Specialty Peptides: What the Evidence Actually Shows
Myostatin inhibitors block the protein that limits muscle growth, but no myostatin-targeting drug is FDA-approved for muscle building in healthy adults.
N-Acetyl Epitalon: What the Research Actually Shows
A guide to N-acetyl epitalon, covering its telomere biology, comparison with standard epitalon, regenerative peptide stacks including BPC-157 and TB-500 fragments, GHRP-2 vs GHRP-6 dosing, and current evidence gaps.
N-Acetyl Semax: What It Is, How It Works, and What the Evidence Actually Shows
A guide to N-Acetyl Semax covering mechanism of action, BDNF effects, comparisons with Semax, Selank, Dihexa, and Cerebrolysin, dosing ranges, and what current research does and does not support.
Nootropic Peptides Overview: Semax, Selank, Cerebrolysin, and Dihexa Explained
A overview of the leading nootropic peptides, including Semax, Selank, Cerebrolysin, and Dihexa. Covers mechanisms, doses, trial data, safety profiles, and prescribing considerations.
Oxytocin Therapeutic: Clinical Uses, Doses, and What the Evidence Actually Shows
A guide to therapeutic oxytocin covering intranasal use, anxiety and autism research, and how it differs from PT-141 (bremelanotide), kisspeptin-10, and DSIP.
P21 Peptide: What It Is, How It Works, and What the Research Actually Shows
A guide to P21 peptide covering its mechanism, comparison with Semax, Selank, Cerebrolysin, and Dihexa, the current evidence base, dosing concepts, and safety considerations.
PE-22-28: The Spadin-Derived Peptide for Depression, Cognition, and Neuroprotection
A guide to PE-22-28, covering its mechanism as a TREK-1 potassium channel blocker, evidence from preclinical studies, comparisons with Semax, Selank, Cerebrolysin, and Dihexa, dosing protocols, and safety data.
PEG-MGF: The Pegylated Muscle Growth Factor Guide for Tissue Repair and Recovery
A deep dive into PEG-MGF, covering its mechanism, dosing protocols, comparison with TB-500 and BPC-157 fragments, the regen peptide stack, and N-acetyl epitalon co-administration.
Peptide Air Shipped: What You Need to Know Before Your Order Arrives
Everything patients need to know about receiving peptides by air shipment: legality, storage on arrival, injection pain, drug testing, and oral bioavailability, with primary-source citations throughout.
Peptide Cycling: What It Is, How to Do It Safely, and What the Evidence Actually Shows
A clinical guide to peptide cycling protocols, legal status in the US, injection technique, oral bioavailability, and drug-test implications. prepared by the HealthRX.com Editorial Team.
Peptide Hair Loss: Which Peptides Actually Work and How to Use Them
A guide to peptides for hair loss, covering GHK-Cu, PTD-DBM, AnaGain, and topical peptide stacks, with dosing, evidence, and what to expect.
Peptide Half-Life Explained: Dosing, Legality, Injection Pain, and Oral Bioavailability
A guide covering peptide half-life science, how long common therapeutic peptides stay active, injection site pain, oral absorption limits, drug-test detection, and US legal status. Includes real doses, named trials, and sourced statistics.
Showing the first 60 matches. Use search or filters to narrow the library.